Dr. Labhasetwar received his undergraduate and Ph.D. degrees in Pharmaceutical Sciences from Nagpur University in India. He was a staff scientist at the National Institute of Immunology in New Delhi (1988-90) before coming to the United States as a postdoctoral fellow in the School of Medicine and College of Pharmacy, University of Michigan, Ann Arbor. After completing his training in 1993, Dr. Labhasetwar continued at the University of Michigan as a faculty member until 1997. He then joined the University of Nebraska Medical Center as Associate Professor of Pharmaceutical Sciences and Biochemistry and Molecular Biology. In February 2007, Dr. Labhasetwar became a Staff member of the Cleveland Clinic's Department of Biomedical Engineering, where he leads the Cancer NanoMedicine program, a collaborative effort jointly sponsored by Biomedical Engineering and the Clinic's Taussig Cancer Center. His research interests are in translational nanomedicine. Dr. Labhasetwar's laboratory investigates nanosystems for drug/gene delivery in cancer therapy, stroke, cardiovascular conditions, and other age-related disorders. He has developed multifunctional magnetic nanoparticles which he is investigating for imaging and targeted delivery of therapeutics in cancer treatment. He also studies nanoparticle-cell interactions to understand the molecular mechanism of intracellular trafficking of nanoparticles. His research has been funded primarily by the National Institutes of Health, the Department of Defense, and the American Heart Association. He has published over 100 peer-reviewed articles and book-chapters, and holds several U.S. and international patents. He has recently co-edited the book, Biomedical Applications of Nanotechnology, which will be published by John Wiley & Sons, Inc., in July 2007. He is the editor-in-chief of Journal of Biomedical Nanotechnology.